hVIVO (LON:HVO) Shares Down 6.8% – Here’s Why

Shares of hVIVO plc (LON:HVO) fell 6.8% on Friday . The stock traded as low as GBX 19 ($0.24) and last traded at GBX 19.10 ($0.24). 2,518,262 shares changed hands during mid-day trading, a decline of 26% from the average session volume of 3,389,765 shares. The stock had previously closed at GBX 20.50 ($0.25).

hVIVO Stock Performance

The company has a quick ratio of 1.16, a current ratio of 1.61 and a debt-to-equity ratio of 33.86. The stock has a market capitalization of £132.67 million, a P/E ratio of 650.00 and a beta of 0.97. The business has a fifty day moving average price of GBX 23.39 and a 200-day moving average price of GBX 26.71.

hVIVO Company Profile

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.